Chronic Pain and Low Testosterone: The Bidirectional Relationship Men Ignore

Men with chronic pain often have low testosterone. Men with low testosterone often have increased pain sensitivity. This bidirectional relationship is rarely discussed in clinical settings, but understanding it changes how chronic pain in men over 40 should be approached.

Pain Suppresses Testosterone

Chronic pain activates the HPA (hypothalamic-pituitary-adrenal) axis - the body's central stress response system. Persistent pain is interpreted as a sustained physiological stressor, resulting in chronically elevated cortisol production.

As detailed in other articles on this site, elevated cortisol suppresses the gonadal axis through several mechanisms: CRH inhibits GnRH at the hypothalamus, cortisol directly suppresses LH production at the pituitary, and direct impairment of Leydig cell testosterone synthesis. The result is lower testosterone across all three dimensions simultaneously.

The research supports this. A 2012 study in Pain examining men with chronic low back pain found testosterone levels significantly below age-matched controls. Multiple studies of men on opioid therapy for chronic pain - opioids directly suppress the hypothalamic-pituitary axis - find testosterone suppression in 40–50% of men on long-term opioids.

Opioid-induced androgen deficiency is a specific, named condition in the endocrinology literature - the direct testosterone-suppressive effect of opioid therapy on the HPG axis. Any man on long-term opioid therapy for pain should have testosterone monitoring as part of their ongoing care. For an alternative to long-term opioids, see my review of the evidence on cannabis for chronic pain in men.

Low Testosterone Amplifies Pain

The pain-testosterone relationship is bidirectional. Low testosterone is independently associated with increased pain sensitivity and lower pain tolerance.

Testosterone has direct analgesic properties through several mechanisms:

• Upregulation of opioid receptors in the CNS
• Direct anti-inflammatory effects (testosterone suppresses TNF-α and IL-1β)
• Modulation of substance P (a neurotransmitter involved in pain transmission)
• Psychological and mood effects that influence pain experience

Multiple human studies have demonstrated that testosterone restoration in hypogonadal men reduces pain scores in conditions including fibromyalgia, chronic musculoskeletal pain, and neuropathic conditions. A 2014 study in Arthritis & Rheumatism found that testosterone levels were inversely correlated with fibromyalgia symptom severity in men.

Inflammation: The Common Driver

Chronic pain produces inflammation. Chronic inflammation suppresses testosterone. Low testosterone reduces the body's anti-inflammatory capacity. This creates a positive feedback loop where each component worsens the others.

The key inflammatory cytokines involved - TNF-α, IL-1β, IL-6 - directly impair Leydig cell function and suppress the HPG axis. This is the same inflammatory cascade that's elevated in chronic pain states, metabolic syndrome, obesity, and sleep-disordered breathing - all of which are more common in men over 40 with chronic pain.

Breaking this cycle requires addressing inflammation directly, not just managing pain symptoms.

Assessment for Men With Chronic Pain

Men over 40 with chronic pain - whether managed with analgesics, opioids, or still seeking adequate treatment - should have regular testosterone monitoring as part of their care. Specifically:

• Total testosterone
• Free testosterone and SHBG (opioids particularly affect SHBG patterns)
• LH (to differentiate opioid/central suppression from primary testicular failure)
• Oestradiol
• Cortisol (morning)
• hsCRP and inflammatory markers

This panel tells you whether low testosterone is contributing to pain burden, whether opioid therapy is causing hormonal suppression, and whether inflammatory load is significant.

At-home comprehensive testing through services like Lola Health covers this full panel without waiting for a GP referral.

Treatment Considerations

For men with low testosterone secondary to chronic pain or opioid therapy:

Address the pain effectively first. This may include exploring all appropriate conventional options - physiotherapy, nerve blocks, pain management clinic referrals - and for men who qualify, legal medical cannabis via a specialist clinic like Releaf. Reducing pain burden reduces the cortisol and inflammatory drive suppressing testosterone.

Consider opioid therapy review. For men on long-term opioids with documented testosterone suppression, a pain management specialist review of whether the opioid therapy is providing adequate benefit relative to its hormonal costs is appropriate.

Address inflammation. Anti-inflammatory lifestyle measures - dietary changes, omega-3 supplementation, exercise (low-impact for pain management), sleep improvement - reduce the inflammatory component of testosterone suppression.

Testosterone replacement may be appropriate for men with significant hypogonadism secondary to chronic pain or opioid therapy that can't be adequately managed. This requires specialist assessment rather than blanket prescribing - the decision needs to account for whether the cause is reversible, the pain management situation, and individual clinical factors.

The Underdiagnosed Dimension

Most chronic pain consultations in the UK don't include hormonal assessment. Most testosterone assessments don't ask about chronic pain burden. The connection between these two dimensions is systematically missed in fragmented healthcare.

For men in their 40s managing chronic pain and wondering why energy, mood, libido, and muscle mass have declined - hormonal assessment is not an afterthought. It may be as relevant to their quality of life as the pain management itself.

---

This article is for educational purposes. Men with chronic pain and suspected hormonal issues should seek clinical assessment from appropriately qualified practitioners.